Fertility Preservation by Endocrine Suppression of Ovarian Function Using Gonadotropin-Releasing Hormone Agonists: The End of the Controversy?

被引：14
|
作者：
Blumenfeld, Zeev [1 ]
机构：
[1] Technion Israel Inst Technol, Haifa, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 19期
关键词：
INTERNATIONAL CONSENSUS GUIDELINES; STEM-CELL TRANSPLANTATION; BREAST-CANCER PATIENTS; YOUNG-WOMEN; GNRH-AGONIST; CHEMOTHERAPY; GOSERELIN; ONCOLOGY; THERAPY; TRIAL;
D O I：
10.1200/JCO.2018.78.9347
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1895 / +
页数：4
相关论文
共 50 条
  • [21] Gonadoliberin (Gonadotropin-Releasing Hormone), Its Agonists and Antagonists
    Holicka, Martina
    Vyslouzil, Jakub
    Kubova, Katerina
    Muselik, Jan
    Vetchy, David
    CHEMICKE LISTY, 2021, 115 (10): : 516 - 523
  • [22] Gonadotropin-Releasing Hormone Agonist Versus Recombinant Human Chorionic Gonadotropin Triggering in Fertility Preservation Cycles
    Herzberger, Einat Haikin
    Knaneh, Sabaa
    Amir, Hadar
    Reches, Adi
    Ben-Yosef, Dalit
    Kalma, Yael
    Azem, Foad
    Samara, Nivin
    REPRODUCTIVE SCIENCES, 2021, 28 (12) : 3390 - 3396
  • [23] Utility of gonadotropin-releasing hormone agonists for fertility preservation in young breast cancer patients: the benefit remains uncertain
    Turner, N. H.
    Partridge, A.
    Sanna, G.
    Di Leo, A.
    Biganzoli, L.
    ANNALS OF ONCOLOGY, 2013, 24 (09) : 2224 - 2235
  • [24] Oncologic Safety of Gonadotropin-Releasing Hormone Agonist for Ovarian Function Protection During Breast Cancer Chemotherapy
    Kim, Hee Jeong
    Lee, Moo Hyun
    Lee, Jeong Eon
    Park, Seho
    Lee, Eun Sook
    Kang, Yong Joon
    Shin, Hae Na
    Kim, Seung Il
    Lee, Jun Ho
    Im, Seock Ah
    Ahn, Sei Hyun
    Lee, Keun Seok
    Sohn, Joohyuk
    Kim, Seonok
    Nam, Seok Jin
    Han, Wonshik
    CLINICAL BREAST CANCER, 2018, 18 (05) : E1165 - E1172
  • [25] Utility of Gonadotropin-Releasing Hormone Agonists for Fertility Preservation: Lack of Biologic Basis and the Need to Prioritize Proven Methods
    Turan, Volkan
    Bedoschi, Giuliano
    Rodriguez-Wallberg, Kenny
    Sonmezer, Murat
    Pacheco, Fernanda Silva
    Oktem, Ozgur
    Taylor, Hugh
    Oktay, Kutluk
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (01) : 84 - +
  • [26] Major depressive symptoms in breast cancer patients with ovarian function suppression: a cross-sectional study comparing ovarian ablation and gonadotropin-releasing hormone agonists
    Jiang, Junhan
    Xu, Junnan
    Cai, Li
    Man, Li
    Niu, Limin
    Hu, Juan
    Sun, Tao
    Zheng, Xinyu
    BMC PSYCHIATRY, 2021, 21 (01)
  • [27] Gonadotropin-releasing hormone agonist for the preservation of ovarian function in survivors of haematopoietic stem cell transplantation for haematological diseases
    Wang, Zhenhong
    An, Jian
    Wang, Chaohua
    BMC WOMENS HEALTH, 2022, 22 (01)
  • [28] Gonadotropin-releasing hormone agonists cotreatment during chemotherapy in borderline ovarian tumor and ovarian cancer patients
    Zhu Hong-lan
    Wang Yan
    Li Xiao-ping
    Wang Chao-hua
    Wang Yue
    Cui Heng
    Wang Jian-liu
    Wei Li-hui
    CHINESE MEDICAL JOURNAL, 2013, 126 (04) : 688 - 691
  • [29] Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis
    Senra, J. C.
    Roque, M.
    Talim, M. C. T.
    Reis, F. M.
    Tavares, R. L. C.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2018, 51 (01) : 77 - 86
  • [30] Are gonadotropin-releasing hormone agonists losing popularity? Current trends at a large fertility center
    Reh, Andrea
    Krey, Lewis
    Noyes, Nicole
    FERTILITY AND STERILITY, 2010, 93 (01) : 101 - 108
12345